InvestorsHub Logo
Followers 1
Posts 158
Boards Moderated 0
Alias Born 05/06/2019

Re: None

Tuesday, 04/13/2021 1:03:06 PM

Tuesday, April 13, 2021 1:03:06 PM

Post# of 3535
FYI - South Korean chipmaker bats US FDA approval of its non-invasive glucose monitoring device

The semiconductor player claims success with D-SaLife in a recent clinical trial involving diabetic outpatients.

https://www.mobihealthnews.com/news/apac/south-korean-chipmaker-bats-us-fda-approval-its-non-invasive-glucose-monitoring-device

South Korean fabless manufacturer Dongwoon Anatech is seeking the approval of both the US and Korean Food and Drug Administration for the commercial rollout of its saliva-based glucose monitoring device after completing its first clinical trial in December.

WHAT IT DOES

The glucose monitoring device called D-SaLife, a product of six years of research and development, makes use of microcurrent control technology in determining the glucose level present in a person’s saliva sample. The meter colour codes the result of the reading which is also recorded through a mobile app.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KNW News